Gear Up for Allstate (ALL) Q4 Earnings: Wall Street Estimates for Key Metrics

Zacks
01-31

The upcoming report from Allstate (ALL) is expected to reveal quarterly earnings of $6.35 per share, indicating an increase of 9.1% compared to the year-ago period. Analysts forecast revenues of $16.71 billion, representing an increase of 12.1% year over year.

Over the last 30 days, there has been a downward revision of 5.3% in the consensus EPS estimate for the quarter, leading to its current level. This signifies the covering analysts' collective reconsideration of their initial forecasts over the course of this timeframe.

Ahead of a company's earnings disclosure, it is crucial to give due consideration to changes in earnings estimates. These revisions serve as a noteworthy factor in predicting potential investor reactions to the stock. Numerous empirical studies consistently demonstrate a strong relationship between trends in earnings estimate revision and the short-term price performance of a stock.

While investors typically use consensus earnings and revenue estimates as indicators of quarterly business performance, exploring analysts' projections for specific key metrics can offer valuable insights.

With that in mind, let's delve into the average projections of some Allstate metrics that are commonly tracked and projected by analysts on Wall Street.

Analysts forecast 'Property-Liability- Net Premiums Earned' to reach $14.00 billion. The estimate indicates a change of +11.1% from the prior-year quarter.

Analysts predict that the 'Corporate and Other- Net Investment Income' will reach $23.16 million. The estimate indicates a change of -3.5% from the prior-year quarter.

Based on the collective assessment of analysts, 'Allstate Health and Benefits- Accident and health insurance premiums and contract charges' should arrive at $479.81 million. The estimate suggests a change of +2.7% year over year.

It is projected by analysts that the 'Allstate Health and Benefits- Other Revenue' will reach $129.41 million. The estimate suggests a change of -8.2% year over year.

Analysts expect 'Property-Liability- Other Revenue' to come in at $472.64 million. The estimate points to a change of +15.3% from the year-ago quarter.

The combined assessment of analysts suggests that 'Allstate Health and Benefits- Net Investment Income' will likely reach $25.87 million. The estimate suggests a change of +17.6% year over year.

The collective assessment of analysts points to an estimated 'Property-Liability- Net Investment Income' of $683.89 million. The estimate suggests a change of +27.1% year over year.

The consensus among analysts is that 'Protection Services- Net Investment Income' will reach $24.41 million. The estimate indicates a year-over-year change of +22%.

The consensus estimate for 'Protection Services- Net Premiums Earned' stands at $679.85 million. The estimate indicates a year-over-year change of +15.8%.

According to the collective judgment of analysts, 'Revenues- Net investment income' should come in at $753.95 million. The estimate suggests a change of +24.8% year over year.

Analysts' assessment points toward 'Policies in force - Allstate Protection - Auto' reaching 24.83 million. The estimate is in contrast to the year-ago figure of 25.28 million.

The average prediction of analysts places 'Policies in force - Allstate Protection - Homeowners' at 7.52 million. Compared to the present estimate, the company reported 7.34 million in the same quarter last year.

View all Key Company Metrics for Allstate here>>>

Allstate shares have witnessed a change of +1% in the past month, in contrast to the Zacks S&P 500 composite's +2.9% move. With a Zacks Rank #3 (Hold), ALL is expected closely follow the overall market performance in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

The Allstate Corporation (ALL) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10